Roivant Sciences Ltd. (ROIV) Insider Trading
Over the last 3 months, ROIV insiders made 0 open-market buys and 7 sales, a net sale of -$29.6M (SEC Form 4). Over the last 6 months, 343 institutions increased and 222 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$29.6M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price -2.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 22, 2026 | Venker Ericofficer: President & Immunovant CEO | Tax | 34,483 | $32.41 |
| May 22, 2026 | Venker Ericofficer: President & Immunovant CEO | Sell | 200,000 | $30.27 |
| May 22, 2026 | Pulik Richardofficer: CFO | Tax | 18,962 | $32.41 |
| May 22, 2026 | Venker Ericofficer: President & Immunovant CEO | Option | 200,000 | $3.85 |
| Apr 22, 2026 | Pulik Richardofficer: CFO | Grant | 60,644 | — |
| Apr 22, 2026 | Venker Ericofficer: President & Immunovant CEO | Sell | 200,000 | $29.59 |
| Apr 22, 2026 | Venker Ericofficer: President & Immunovant CEO | Option | 200,000 | $3.85 |
| Apr 22, 2026 | Humes Jenniferofficer: Chief Accounting Officer | Grant | 27,157 | $29.08 |
| Apr 22, 2026 | Humes Jenniferofficer: Chief Accounting Officer | Grant | 29,173 | — |
| Apr 22, 2026 | Pulik Richardofficer: CFO | Grant | 84,026 | $29.08 |
| Apr 21, 2026 | MOMTAZEE JAMES Cdirector | Tax | 94 | $29.83 |
| Apr 21, 2026 | Epperly Melissa B,director | Grant | 670 | — |
| Apr 21, 2026 | MOMTAZEE JAMES Cdirector | Grant | 469 | — |
| Apr 21, 2026 | Oren Ilandirector | Tax | 95 | $29.83 |
| Apr 21, 2026 | Oren Ilandirector | Grant | 896 | — |
| Apr 20, 2026 | Gline Matthewdirector, officer: CEO | Sell | 289,774 | $29.16 |
| Apr 10, 2026 | Humes Jenniferofficer: Chief Accounting Officer | Sell | 13,538 | $28.37 |
| Apr 2, 2026 | Torti Frankofficer: President and Vant Chair | Tax | 160,035 | $27.70 |
| Apr 1, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Tax | 187,512 | $27.70 |
| Apr 1, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Option | 1,306,889 | — |
| Apr 1, 2026 | Gline Matthewdirector, officer: CEO | Tax | 304,684 | $27.70 |
| Apr 1, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Option | 58,391 | $12.68 |
| Apr 1, 2026 | Gline Matthewdirector, officer: CEO | Option | 97,319 | $12.68 |
| Apr 1, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Tax | 29,809 | $26.41 |
| Apr 1, 2026 | Gline Matthewdirector, officer: CEO | Tax | 53,826 | $26.41 |
| Apr 1, 2026 | Gline Matthewdirector, officer: CEO | Option | 2,178,150 | — |
| Mar 30, 2026 | Fitzgerald Meghandirector | Option | 70,000 | $8.80 |
| Mar 30, 2026 | Fitzgerald Meghandirector | Sell | 70,000 | $27.45 |
| Mar 24, 2026 | Humes Jenniferofficer: Chief Accounting Officer | Tax | 14,526 | $27.70 |
| Mar 24, 2026 | Pulik Richardofficer: CFO | Tax | 1,546 | $27.70 |
Source: ROIV SEC Form 4 filings, latest May 22, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ROIV positions over the last 6 months (SEC Form 13F).
Increased
343
New positions
188
Reduced
222
Sold out
87
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 78.0M | May 15, 2026 |
| FMR LLC | Increased | 65.8M | Feb 17, 2026 |
| MORGAN STANLEY | Increased | 58.4M | Feb 13, 2026 |
| MORGAN STANLEY | Reduced | 51.8M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 44.3M | May 13, 2026 |
| VANGUARD GROUP INC | Increased | 42.1M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 41.2M | Feb 12, 2026 |
| QVT FINANCIAL LP | Reduced | 26.4M | Feb 13, 2026 |
| QVT FINANCIAL LP | Reduced | 25.2M | May 15, 2026 |
| UBS GROUP AG | Increased | 22.6M | May 5, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 20.7M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 19.8M | May 8, 2026 |
| UBS GROUP AG | Increased | 18.4M | Jan 29, 2026 |
| STATE STREET CORP | Reduced | 17.4M | Feb 13, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 16.6M | May 29, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.